Synthesis of fluoro analogues of 3,4-(methylenedioxy)amphetamine (MDA) and its derivatives.
Daniel Trachsel, Marcel Hadorn, Franz Baumberger
Chemistry & Biodiversity March 2006 DOI: 10.1002/cbdv.200690035 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Theoretical or philosophical paper Peer reviewed |
|---|---|
| Key points | The authors synthesized six new 3,4-(difluoromethylenedioxy) analogues of MDMA and propose that their fluorine atoms may prevent formation of toxic radical-pathway metabolites. They argue these compounds could help test the hypothesis that MDMA-induced neurotoxicity arises from metabolites lacking the methylenedioxy bridge. |
Abstract
The role of the metabolism of the entactogen 3,4-(methylenedioxy)methamphetamine (MDMA; 1b) in neurotoxic or psychopharmacologic action is widely discussed, but not yet fully understood. To prompt further investigation into the role of MDMA metabolism, six new 3,4-(difluoromethylenedioxy) analogues of MDMA (1b) were prepared and characterized. Although electronically very different, the fluoro analogues 3-5 should be sterically very similar to the non-fluorinated parent compounds. The F-atoms may prevent the formation of toxic metabolites produced via a radical pathway (Scheme 1). Different theories regarding MDMA-induced neurotoxicity are briefly reviewed and discussed. The novel compounds 3-5 may help to verify the hypothesis that MDMA-induced neurotoxicity is the result of the formation of metabolites lacking the methylenedioxy bridge.
Citations in the library
Cited by 3
- Fluorine in psychedelic phenethylamines Drug Testing and Analysis February 28, 2012
- Pharmacological characterization of 3,4-methylenedioxyamphetamine (MDA) analogs and two amphetamine-based compounds: ,α-DEPEA and DPIA European Neuropsychopharmacology April 1, 2022
- Crystal Structure of a Fluoro Analogue of 3,4-(Methylenedioxy)amphetamine 2015
Cites 30
- Positron emission tomographic evidence of toxic effect of MDMA (“Ecstasy”) on brain serotonin neurons in human beings The Lancet October 1, 1998
- Human Pharmacology of MDMA Therapeutic Drug Monitoring March 19, 2004
- Small Changes in Ambient Temperature Cause Large Changes in 3,4-Methylenedioxymethamphetamine (MDMA)-Induced Serotonin Neurotoxicity and Core Body Temperature in the Rat Journal of Neuroscience July 1, 1998
- Reducedin vivobinding to the serotonin transporter in the cerebral cortex of MDMA (‘ecstasy’) users The British Journal of Psychiatry July 1, 1999
- Which neuroreceptors mediate the subjective effects of MDMA in humans? A summary of mechanistic studies Human Psychopharmacology: Clinical and Experimental December 1, 2001
and 25 more in the library